Custom Search

News

Monday 01 March 2004

High incidence of neutropenia in patients treated with rituximab after autologous stem cell transplantation.

By: Cairoli R, Grillo G, Tedeschi A, D'Avanzo G, Marenco P, Morra E.

Haematologica 2004 Mar;89(3):361-3

We report a high incidence of neutropenia in patients treated with rituximab prior to and following autologous stem cell transplantation (ASCT). Fourteen patients with follicular or mantle-cell lymphoma were treated with high dose (HD) therapy followed by an in vivo-purged autologous graft.

Use of this site is subject to the following terms of use